Immunotherapy Approaches in T-Cell Lymphoma: Highlights From SOHO 2021
Kelly Valla, PharmD, BCOP
J Adv Pract Oncol 2022;13(suppl 1):31–33 |
© 2022 Harborside™
At the 2021 SOHO Annual Meeting, Maksim Mamonkin, PhD, of Baylor College of Medicine, reviewed progress in immunotherapy for T-cell lymphoma. Kelly Valla, PharmD, BCOP, of Winship Cancer Institute of Emory University, discusses key insights from this session for advanced practitioners.
For access to the full length article, please sign in